惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

WordPress大学
WordPress大学
Stack Overflow Blog
Stack Overflow Blog
人人都是产品经理
人人都是产品经理
Y
Y Combinator Blog
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
D
DataBreaches.Net
GbyAI
GbyAI
Microsoft Security Blog
Microsoft Security Blog
博客园_首页
大猫的无限游戏
大猫的无限游戏
Jina AI
Jina AI
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
Engineering at Meta
Engineering at Meta
IT之家
IT之家
MongoDB | Blog
MongoDB | Blog
The GitHub Blog
The GitHub Blog
月光博客
月光博客
U
Unit 42
Hugging Face - Blog
Hugging Face - Blog
博客园 - 叶小钗
腾讯CDC
B
Blog RSS Feed
博客园 - Franky
爱范儿
爱范儿

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Novo Nordisk A/S (NOVO:CA) Q1 2026 Earnings Call Transcript
2026-05-07 · via All Articles on Seeking Alpha

Novo Nordisk A/S (NOVO:CA) Q1 2026 Earnings Call May 6, 2026 7:00 AM EDT

Company Participants

Michael Novod - Senior VP & Head of Investor Relations
Maziar Doustdar - President, CEO & Member of the Management Board
Jamey Millar - Executive VP of US Operations & Member of Management Board
Emil Larsen - EVP of International Operations & Member of Management Board
Karsten Knudsen - Executive VP, CFO & Member of the Management Board
Martin Lange - EVP of R&D, Chief Scientific Officer and Member of the Management Board

Conference Call Participants

Richard Vosser - JPMorgan Chase & Co, Research Division
Sachin Jain - BofA Securities, Research Division
Simon Baker - Rothschild & Co Redburn, Research Division
Peter Verdult - BNP Paribas, Research Division
Michael Leuchten - Jefferies LLC, Research Division
Michael Nedelcovych - TD Cowen, Research Division
James Gordon - Barclays Bank PLC, Research Division
Evan Seigerman - BMO Capital Markets Equity Research
James Quigley - Goldman Sachs Group, Inc., Research Division
Graham Glyn Parry - Citigroup Inc., Research Division
Florent Cespedes - ODDO BHF Corporate & Markets, Research Division
Carsten Madsen - Danske Bank A/S, Research Division

Presentation

Operator

Good day, and thank you for standing by. Welcome to the Q1 2026 Novo Nordisk Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

I would now like to hand the conference over to your first speaker today, Michael Novod, Head of Investor Relations. Please go ahead.

Michael Novod
Senior VP & Head of Investor Relations

Thank you very much, operator. Welcome to this Novo Nordisk earnings call for the first 3 months of 2026. My name is Michael Novod, I'm the Head of Investor Relations at Novo Nordisk. With me today, I have CEO of Novo Nordisk, Mike Doustdar; EVP, U.S. Operations, Jamey Millar; EVP, International Operations, Emil Kongshoej Larsen; EVP, Research and Development and Chief Scientific Officer, Martin Holst Lange; and Chief Financial Officer, Karsten Knudsen.